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Abstract

This study evaluates the use of nanotubes (NTs) as a matrix for local drug delivery modified by a
biodegradable polymeric coating on medical-grade nitinol (NiTi alloy) surfaces. For this purpose, NiTi

was anodized within parameters that promote the formation of NTs, ultrasonicated, annealed and
impregnated with vancomycin hydrochloride. To improve bioperformance, poly(lactic-co-glycolic acid)
(PLGA) was also deposited on the drug-loaded NTs. The samples were characterized in terms of
structure, wettability, drug delivery, corrosion and cytocompatibility. Scanning electron microscopy
and water contact angle measurements signify the formation of open-top homogeneous NTs of 600–
700 nm in length and ~30 nm in diameter with improved hydrophilicity. The bare antibioticimpregnated NTs exhibit a burst release of about 49% of the loaded drug in the first 6 h of soaking in a
physiological medium, followed by the entire drug diffusing out before 96 h. The PLGA coating
effectively controls the burst release of vancomycin to 26% and retains almost 50% of the loaded drug
beyond 7 days. The kinetics of the different vancomycin-release stages is also correlated to several
well-established models. As a comparative criterion of metallic ions leaching kinetics, the corrosion
resistance of nitinol is found to be reduced by the formation of the NTs, while the PLGA coating
enhances this electrochemical feature. Due to the alteration of the drug delivery and corrosion
protection, the PLGA-coated vancomycin-impregnated sample presents a higher dental pulp stem cell
viability in comparison to both the bare drug-loaded and non-loaded NTs. In conclusion, PLGA-coated
vancomycin-loaded NT-covered NiTi can be effectively used as a controlled drug-delivery device, while
having a drug-release dosage within the therapeutic window and a minimal negative effect on
biocompatibility.
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1. Introduction

Nearly-equiatomic NiTi alloy has long been under consideration for further development and
expansion of biomedical applications, especially in orthopedics that exploit a unique combination of
mechanical properties (shape-memory effect, low stiffness, high fatigue and wear resistance) and
decent biocompatibility of this alloy [[1], [2], [3]]. Nevertheless, orthopedic operations involving
implants are generally prone to post-surgery infections, a serious condition that can lead to morbidity,
the need for revision surgery and in severe cases even mortality [4] unless addressed therapeutically.
The classical approach for infection prevention at the implantation sites is the prolonged, high-dose
intravenous systemic antibiotic administration which bears several well-documented shortcomings,
such as poor antibiotic biodistribution, uncontrollable pharmacokinetics and serious side effects for
non-target organs [5,6]. An alternative approach for infection prophylaxis in implanting operations is
the employment of local drug-delivery strategies, ranging from antibiotic-loaded poly(methyl
methacrylate) beads and bone cements [7,8] to drug-impregnated surface-modified titanium alloy
implants in which anodically-grown nanotubes (NTs) act as drug reservoirs [[9], [10], [11], [12]].
Drug-loaded NTs on titanium alloys have shown the ability to satisfy the requirements of successful
local drug-delivery devices, in terms of effective therapeutic drug doses continually delivered to the
target site over prolonged periods [13,14]. Nonetheless, drug-loaded NTs are notorious for the rapid
release of their therapeutic load [15,16] since it can lead to adverse effects, e.g. the drug toxicity and
the inability to sustained long-term drug release. Different solutions have been explored to control the

drug-release rate from these NTs. Applying biodegradable polymer coatings is one of the most
effective approaches in modulating the drug-release kinetics from NTs. To do so, chitosan and
poly(lactic-co-glycolic acid) (PLGA) are top candidates because both are highly biocompatible and have
shown an antibacterial ability along with improved osseointegration [9].
Anodization in fluoride-containing electrolytes is a common approach for the fabrication of
geometrically tunable NTs on the surface of titanium and its alloys [17]. This approach has been
successfully extended for the formation of NTs on other Ti-X alloys with varying success [18,19] that
mainly depends on the type and concentration of alloying element. For example, NTs can be anodically
produced on Ti Zr alloys in a wide range of Zr concentrations as Zr is a valve metal. In contrast, the
anodic fabrication of NTs on Ti Ru alloys is limited at Ru contents higher than 5 at.% since non-valve
Ru lacks the ability to form a compact passive layer upon reaction with oxygen. In case of nearlyequiatomic NiTi alloy having a high concentration of non-valve Ni, anodization in fluoride-containing
electrolytes has been proven to produce NTs [[20], [21], [22]], albeit in a narrow range of fabrication
parameters compared to Ti.
To the best of our knowledge, there is no report in the literature on the drug impregnation of NTs
grown on NiTi alloy. In this study, NTs are fabricated on the surface of NiTi alloy by anodization in an
electrolyte reported elsewhere [22,23] to assess the feasibility of using NTs as a platform for the
controlled local delivery of a model antibiotic agent for the first time in the relative literature.
Vancomycin hydrochloride, a highly water-soluble glycopeptide antibiotic which is commonly
prescribed for the treatment of osteomyelitis caused by Staphylococcus aureus gram-positive bacteria
[24] was selected as the model drug for incorporation into the NTs grown on NiTi. PLGA coating on the
drug-loaded NTs is also followed to modulate the drug-release kinetics as this biopolymer is more
versatile than chitosan in terms of tuning its degradation rate and its chain's relative
hydrophilicity/hydrophobicity. In PLGA, lactic (less hydrophilic chains) to glycolic (more hydrophilic
chains) monomer ratio determines the polymer's water-uptake, influencing its degradation rate
[[25], [26], [27]]. Based on these assumptions, PLGA 75:25 is selected for its longer degradation rate
and higher hydrophobicity, which can further delay the diffusion of highly hydrophilic vancomycin
molecules. The prepared samples are afterwards compared from drug-delivery, corrosion and cell
cytocompatibility viewpoints.

2. Materials and methods
2.1. Materials

The materials used in this study include medical-grade Ni 50Ti disks (Kellogg's Research Labs, USA) of
9 mm in diameter as the substrates, ethylene glycol (Reag. USP grade, Merck, Germany) and
ammonium fluoride (ACS grade, Merck, Germany) as the anodization electrolyte, vancomycin
hydrochloride (molecular biology grade, Alfa Aesar, USA) as the incorporating drug, double-distilled
water (purity: 99%, conductivity: 1 μs·cm−1) as the solvent and PLGA (LA/GA ratio: 75:25, acidterminated, Corbion, Netherlands) as the coating agent.

2.2. Fabrication of NTs

The NiTi disks were first ground, polished and washed under ultrasonication in ethanol and distilled
water. The non-working side of the disks was coupled to a copper wire via copper tapes and sealed

with silicone rubber. Each of the surface-processed samples were anodized in 100 ml of an ethylene
glycol-based electrolyte containing 0.2 wt% NH4F and 1 vol% H2O at 25 V for 60 min, in accordance
with Refs. [18,28], in a two-electrode cell with a cathodic Pt sheet of 12 ∗ 12 mm2 in area at room
temperature. The distance between the cathode and the working electrode was set at 20 mm. In order
to remove debris from the formed NT tops, ultrasonic cleaning in successive ethanol and distilled water
for 5 and 10 min was also conducted. The samples were also heat-treated at 600 °C for 1 h with the
heating and cooling rate of 3 °C/min under vacuum, based on Refs. [28, 29], to ensure an optimal
combination of wettability, biocompatibility, corrosion and bioactivity characteristics. Typically, the
employed annealing temperature has been reported to retain the superelasticity and shape-memory
characteristics of NiTi [30], giving transformation temperatures appropriate for biomedical applications
[31]. The morphology of the samples was investigated by a field-emission scanning electron
microscope (FESEM, TESCAN, MIRA 3).

2.3. Wettability measurement

For wettability studies, the sessile water drop technique was used by pipetting five microliters of
double-distilled water on the samples. The ImageJ software was used to measure the contact angle
between the drop contour and software-defined baseline. The procedure was repeated three times on
different surface spots of the samples and the average values were reported.

2.4. Antibiotic loading and PLGA coating

The annealed samples were loaded with vancomycin as a model antibiotic drug via the setup of Ref.
[32]. In summary, one sample was put in a 15 ml falcon tube with a bore in its plastic cap. The falcon
tube was placed upside-down in a 250 ml round-bottom flask. After the flask evacuation for 30 min, a
10 mg/ml vancomycin aqueous solution was introduced to the setup and left for 24 h to ensure the
maximum drug molecule adsorption on NT walls. Subsequently, the samples were dried at room
temperature for 24 h in air.
The drug-loaded samples were cleaned with a soft tissue and rinsed with the phosphate buffer saline
(PBS) solution briefly to remove any excess drug from the surface before polymer coating. Afterwards,
the drug-loaded samples were dipped in a 1% (w/v) PLGA solution dissolved in acetone with the
immersion time of 10 s. Then, the samples were dried at 50 °C for 15 min.

2.5. Drug-release characterization

The release of vancomycin from the bare and PLGA-coated drug-loaded samples was investigated by
immersing the samples in 10 ml of PBS at 37 °C. At intervals of 1, 3, 6, 9, 12, 24, 48, 72, 96, 120, 144
and 168 h, 4 ml of the medium was taken and refreshed. The amount of the drug released into the PBS
was measured by ultraviolet-visible spectroscopy (UV–vis, Perkin Elmer, Lambda 14) with a resolution
of 1 nm at 280 nm. The drug concentration was calculated from calibration curves obtained for known
vancomycin concentrations in PBS. The total amount of the loaded drug was also determined when the
UV–vis spectra showed no further absorbance changes at 280 nm. The measured experimental data
was also further analyzed by fitting with several well-established drug-delivery models, where the
goodness-of-fit was determined based on the closeness of linear correlation coefficient (Rc) to the unit.

2.6. Corrosion studies

The open circuit potential (OCP) of the samples in the PBS solution at 37 °C was recorded. After
reaching a steady-state OCP (2 h), potentiodynamic polarization was conducted with a scan rate of
1 mV/s in a potential range of −0.8 V to +1.5 V, using a potentiostat (Radstat 10, Kianshar Danesh Co.)
with a Pt counter electrode and AgCl/Ag reference electrode at 37 °C. The exposed surface area of the
samples in the corrosion studies was equal to 0.635 cm2.

2.7. In vitro cytocompatibility assessment

The MTT assay was performed to determine the dental pulp stem cell (DPSC) viability on the samples.
Each experiment was performed in triplicate at the specified culture durations of 1, 3 and 7 days in a
48-well plate, as reported previously [33] with some modifications. At the desired periods, the culture
medium was removed, and 100 μl of 0.5 mg/ml MTT solution in the medium was added to each well
and incubated for 4 h at 37 °C. Thereafter, 100 μl of dimethyl sulfoxide (DMSO) solution was added to
each well to dissolve formazan crystals. Finally, the solution was transferred to a 96-well plate to
determine the optical density values at the wavelength of 545 nm using a microplate reader
(ChroMate-4300, FL, USA). The one-way analysis of variance (ANOVA) with a statistical significance
level of <5% (p-value < 0.05) was used to compare the cytocompatibility data.

3. Results and discussion
3.1. Morphological studies

Fig. 1(a) represents the FESEM micrograph of the as-anodized sample. NTs are not completely evident
in this sample because their tops are covered by debris and precipitates from the electrolyte [34],
which makes these NTs unsuitable for drug loading due to the blockage of the matrix. To clean the NT
tops from these deposits, anodization was followed by ultrasonication. Since there is no information in
the literature, to our knowledge, on optimized conditions under which sonication of anodized NiTi
produces open-top NTs, two sonication processes were experimented. Based on Fig. 1(b), sonication
for 5 min (2.5 min in ethanol and 2.5 min in distilled water) successfully develops open-top NTs via the
desorption of the physically deposited debris. This sample also exhibits a homogenous feature of NTs
grown over the whole investigated area with minimal damage. Although by increasing sonication to
10 min (5 min in ethanol and 5 min in distilled water) a precipitate-free surface is still obtained, the
excess energy provided by longer sonication results in the damage and removal of NTs from some
areas, according to Fig. 1(c). Therefore, it is concluded that the optimized duration of sonication is
5 min to achieve open-top non-detached NTs. Thereafter, the anodized samples for further studies are
processed with the mentioned parameters to ensure a maximum drug loading capacity.

Fig. 1. FESEM micrograph of the samples processed by anodization (a), anodization followed by sonication for
5 min (b) and anodization followed by sonication for 10 min (c).

The anodized, sonicated NiTi samples were heat-treated at 600 °C for three purposes. First,
anodization in fluoride-containing electrolytes has been reported to leave organic residues like
[TiF4]2− on the surface. This not only decreases the biocompatibility of the device but also increases the
bacterial adhesion to the surface disadvantageously, which can be overcome by annealing at above
500 °C [16,35]. Second, previous surface-compositional studies have shown that the annealing scheme
applied in this work decreases the level of Ni from 2.15 at.% to 1.90 at.%, which is accompanied by a
reduction of the Ni/Ti ratio from 0.23 to 0.13 [28]. This decrease is favorable for long-term biomedical
applications of the related devices as it can lead to improved biocompatibility. Third, annealing at
600 °C can beneficially affect the crystallinity of NTs by promoting the formation of the rutile phase
[20,36].
Fig. 2(a) and (b) depicts NTs after annealing. As evidenced, the NTs show no morphological collapse
after annealing, as compared to Fig. 1(b). The average diameter of the NTs is estimated to be
approximately 35 nm, which is within the optimal range for the highest cell differentiation ability [37].
The mean length of the NTs is also measured to be almost 600 nm, based on the tilted view of the
sample (Fig. 2(c)). The dimensions of the obtained NTs are consistent with the literature [18,38,39],
where there is a limit for the maximum achievable length of anodically-produced NTs on NiTi. This is
due to the high concentration of non-valve Ni in NiTi with little potential to form compact oxides upon
oxidation unlike valve Ti and also to the higher solubility of nickel oxides compared to titanium oxides
in the presence of fluorine [16]. It is also noticeable that the produced NTs exhibit the highest
achievable length-to-diameter ratio reported to date, which is critical for a high drug loading capacity
and low burst drug release [15,40].

Fig. 2. FESEM micrograph of the sample subjected to the sequence of anodization, sonication and annealing
from top views in two magnifications (a, b) and a tilted view (c).

The FESEM micrograph of the drug-loaded NTs before and after PLGA coating is indicated in Fig. 3.
From the re-blockage of the NT tops in Fig. 3(a), it is inferred that the drug is successfully penetrated
inside the NTs and intertubular spaces with a homogeneous distribution on the whole surface of the
disks. Fig. 3(b) also demonstrates the successful uniform deposition of PLGA on the NTs tops, where
the depressions of the biopolymer film are indicative of the pore opening structure of the NTs beneath
the coating.

Fig. 3. FESEM micrograph of the NTs loaded with vancomycin from a top view (a) and coated with PLGA from a
tilted view (b).

3.2. Water contact angle measurements

The wettability of implants has a determining effect on the protein adsorption, biocompatibility and
bioactivity of the devices [29,41]. In this regard, bone/cell adhesion, proliferation and mineralization
are found to be promoted by increasing the surface hydrophilicity. In addition, it is logically anticipated
that water-soluble drugs like vancomycin have a facilitated and therefore increased incorporation into
more hydrophilic matrixes. Fig. 4 signifies the side-view of water drops on the as-ground, as-anodized
and annealed samples. The as-ground NiTi sample exhibits a sessile water contact angle of 63.1 ± 2.9°,
which is controlled by the naturally-formed oxide layer on its surface [42]. The contact angles
measured on the as-anodized and annealed samples are equal to 55.2 ± 3.34° and 43.2 ± 2.7°,
respectively. The enhancement in wettability after anodization is attributed to hydroxylation (the
formation of surface Ti-OH groups) and roughening. Indeed, the formed NTs and intertubular spaces
can allow the liquid penetration and accordingly decrease the contact angle [43]. The further increase
of hydrophilicity after annealing is attributed to the crystallization of the NTs. The effect of annealing
schemes on the crystallinity of mostly amorphous NTs anodically grown on NiTi has been extensively
discussed in the literature, where it has been reported that annealing at 400–500 °C and beyond 550 °C
promotes the formation of anatase and rutile crystalline phases, respectively [20,23,29].

Fig. 4. Side-view macrograph of water drops on the as-ground (a), as-anodized (b) and annealed (c) samples.

3.3. Drug-delivery kinetics studies

The concentration and cumulative percentage of vancomycin released from the devices are revealed
in Fig. 5(a) and (b), respectively. Both of the sample sets display a biphasic behavior, including a sharp
onset of the drug release during the first 12 h for the bare sample and the first 6 h for PLGA-coated
sample, along with a subsequent slower sustained release in the next durations. For the bare NTs, the
initial burst release is characterized by about 74.0% of vancomycin into the PBS until 12 h, followed by
a slower release of remaining vancomycin until 96 h. The reason behind the initial burst release is
postulated to be a steep gradient of the drug concentration at the NTs-PBS interface. It is believed that
the drug molecules physically-adsorbed on the NT tops and intertubular spaces which are in immediate
contact with the PBS media are released at this stage. The sustained release of vancomycin in the later
84 h is also attributed to the drug molecules deeply-incorporated in the nanotubular structure acting
as a stable reservoir of the drug. The drug-delivery kinetics from similarly-sized NTs grown on Ti alloy
substrates has been reported to be 100% of release by 6–12 h [15,16,44]. In comparison to the
literature, this prolonged release of the drug explored in this work can be due to several reasons. First
and foremost, the drug is loaded in the NTs through a vacuum technique in this study, which
significantly increases the drug-loading and incorporation levels into the NTs. Capillary forces caused
by the small dimensions of NTs and also air molecules residing on the top of NTs during the drugloading stage limit the amount and depth of the drug penetration into the NTs. Drug-loading
techniques like pipetting and immersion used in many previous studies [13,14,45] rely only on the
force of gravity and surface adsorption, which results in the partial impregnation of NTs [46]. The
vacuum-loading technique not only can counter the air molecules hindering the drug penetration but
also provide an additional force to incorporate the drug further in the length of NTs. Another
considerable aspect that can affect the drug-loading behavior of the bare NTs is their lowered water
contact angle after annealing and crystallization into rutile. Vancomycin is a highly water-soluble drug
having a hydrophilic nature, so that water-dissolved vancomycin loading into surfaces can be facilitated
by using lower water contact angles. This can result in an easier penetration of drug molecules into the
depth of NTs and accordingly a slower release kinetics evidenced in this study. Additionally, annealing

of NTs at 600 °C has been reported to cause the formation of OH− groups on the surface of NTs [29].
These negatively-charged groups can interact with the naturally-positive charge of vancomycin, leading
to a further delay in the drug-release kinetics.

Fig. 5. Concentration (a) and cumulative percentage (b) of the drug released from the devices.

In comparison to the bare NTs, the PLGA coating of the drug matrix provides a substantial alteration in
the release kinetics. Under this condition, the burst release in the first 6 h is reduced from 48.6% to
26.0%. Additionally, the polymer-coated sample continues to release vancomycin beyond the 7th day
of the release study with only 56.0% release of the total loaded vancomycin amount at the end of the
7th day. Further testing showed that a soaking period of 14 days is required for the entire release of
vancomycin loaded. Generally, the release of drugs from polymer-coated surfaces is dependent on the
polymer degradability, thickness, permeability and interaction with the diffusing drug [47,48]. PLGA is
biodegraded through water uptake and swelling accompanied by the hydrolysis and cleavage of its
backbone. When the thin layer of PLGA on the NTs comes in contact with PBS initially, it rapidly starts
swelling, thereby leading to a burst release of 26.0%. This is followed by a reduced degradation rate
because PLGA used in this work enjoys the specification of LA/GA = 75:25. That is, PLGA with the high
LA fraction in its network is less hydrophilic and therefore has a lower hydrolysis degradation rate.
Also, due to the presence of more hydrophobic LA monomers, the diffusion of highly hydrophilic drugs
such as vancomycin becomes more difficult, resulting in a longer release period. This notion is
corroborated by the slowed out-diffusion of vancomycin in the media, which is extended to up to
14 days in the PLGA-coated NTs.
It is vital that the concentration of vancomycin in the medium over the soaking period to be within the
therapeutic window for a successful local drug-delivery system. For vancomycin, this translates into
meeting the minimum inhibitory concentration (MIC) needed for the effective countering of bone-

related bacterial infections. S. aureus are gram-positive bacteria that are responsible for most postsurgery infections and are effectively and routinely countered by the systematic administration of
vancomycin after surgeries. Vancomycin has been reported to have a MIC of 1–10 μg/ml, based on in
vitro studies conducted on S. aureus cultured colonies [16,49]. For both of the samples and the entire
drug-release periods, it is seen in Fig. 5(a) that the vancomycin concentration is consistently above the
MIC value of S. aureus. From this viewpoint, the ability of these local drug-delivery platforms to release
an antibacterial agent within its therapeutic window and, in theory, to successfully stop the bacterial
proliferation and biofilm formation is realized. Nevertheless, to ensure the control of osteomyelitis, the
MIC level should be met for at least two weeks [50], which is not satisfied with the bare NTs. Thus, it is
logically anticipated that the PLGA-coated sample provides a safer treatment of osteomyelitis.
To further analyze the drug-delivery kinetics from the bare and PLGA-coated NTs, the experimental
vancomycin-release data of both burst and sustained stages was fitted with the Higuchi [51], zeroorder [52] and first-order models [53]. Based on Table 1 which lists Rc values, the bare drug-loaded NTs
show the best fit with the first-order model during the first 6 h (Fig. 6(a)) and with the Higuchi kinetics
during the remaining period of vancomycin release (Fig. 6(b)). The assignment of a burst drug release
kinetics for the first 6 h from the bare NTs is in good agreement with the physical basis of the firstorder model which is essentially established for a fast and concentration-dependent drug delivery. The
following sustained release stage, which was above attributed to the deeply-incorporated remaining
drug molecules, is verified by the domination of the diffusion-controlled Higuchi kinetics. The
unsuitable fit of the bare sample data with the zero-order kinetics is also due to the much larger
diameter of the NTs (~30 nm) than eluting vancomycin molecules (~3 nm) [54].
Table 1. Linear correlation coefficient (Rc) values of the drug-delivery kinetics fits.
Model

Rc for the bare NTs
Burst stage
Higuchi
0.91
First-order 0.99
Zero-order 0.85

Rc for the PLGA-coated NTs
Sustained stage Burst stage
0.99
0.98
0.85
0.91
0.82
0.89

Sustained stage
0.99
0.87
0.83

Fig. 6. Drug-release fitting curves of the first-order (a) and Higuchi (b) models for the bare NTs, and the Higuchi
(c) and Korsmeyer-Peppas (d) models for the PLGA-coated NTs.

In accordance with Table 1, the vancomycin-release data for the PLGA-coated sample reveals the best
fit with the Higuchi kinetics for both the burst and sustained stages. In comparison to the bare NTs, the

transformation of the fast first-order release to the diffusion-controlled Higuchi kinetics for the initial
release phase is indicative of the shortening of the burst kinetics as a result of the PLGA coating. The
fact that the PLGA-coated NTs continues to have a good fit with the Higuchi kinetics in the sustained
phase suggests a diffusion-controlled mechanism of vancomycin release. Biodegradable polymers used
as a barrier for controlled drug-delivery applications tend to introduce both diffusion- and degradationcontrolled mechanisms to the underlying drug-loaded substrates. The relatively low degradation rate
of 75:25 PLGA during the 7-day release study is thought to be the reason for the continued diffusioncontrolled mechanism for the polymer-coated sample. To further explore the elution kinetics of the
coated sample, the Korsmeyer-Peppas model [53] which can also account for non-Fickian behaviors is
employed. The value n in this model can characterize different release mechanisms, so that for thin
films n < 0.5 indicates a diffusion-controlled mechanism, while n > 1 is interpreted as degradationcontrolled. Values between these bounds hint at the superposition of both mechanisms. The PLGAcoated sample presents a good fit with the Korsmeyer-Peppas model at both stages, where the values
obtained for n are 0.34 for the burst stage and 0.86 for the sustained stage. This implies that the
driving force of diffusion is reduced by increasing the elution time, indicating the onset of PLGA
degradation which is not yet rapid enough during the 7-day study to dominate the release mechanism.

3.4. Electrochemical corrosion evaluation

The variations of OCP vs. immersion time in PBS and the potentiodynamic polarization curves of the
mechanically-ground, as-anodized, annealed, and PLGA-coated samples in terms of potential (E) and
current density (i) are presented in Fig. 7. As revealed in Fig. 7(a), for the as-ground sample, the OCP
displays a sharp increase at the onset of immersion, followed by stabilization at approximately −0.2 V.
Preferential and spontaneous oxidation of Ti atoms in PBS leads to the evolution of an oxide layer on
the surface until a balance between oxidation and dissolution is established [29], where the diffusion
of oxidizers in the oxide layer is limited by increasing the oxide thickness. The as-anodized samples
display a relatively stable potential with a slight increase during 2 h of immersion, which is thought to
be due to a compromise of the anodization-assisted formation of an oxide layer and oxidation
reactions taking place at defects of the NT layer. Annealing of the NTs increases the OCP to more
positive values, due to the further oxidation of the substrate through defects of the NT layer. The
PLGA-coated sample is also shown to have a stable OCP, which is attributed to the thin PLGA layer
hampering the charge transfer at the electrode/electrolyte interface.

Fig. 7. Open circuit potential (a) and potentiodynamic polarization (b) curves of the samples.

According to the polarization curves (Fig. 7(b)), it is observed that the as-ground sample displays higher
corrosion resistance than both of the as-anodized and annealed NT-covered samples. This is consistent
with previous reports that show anodization declines corrosion resistance, despite the fact that this
process promotes that formation of a thick oxide layer on NiTi [22]. This is attributed to the fact that
NTs essentially provide larger surface areas than the naturally-formed oxide layer of the as-ground
sample and act as pathways for mass-transport phenomena such as corrosion. Annealing of the NTs at
600 °C is realized to increase the corrosion resistance slightly. Based on the literature [29,36], it has
been established that by the annealing scheme used in this study, the crystallinity of the as-anodized
sample is increased. The formed crystalline NTs are believed to benefit from grains and grain
boundaries acting as potential sites for the nucleation of a passive layer when exposed to corroding
media [55,56], thereby improving the corrosion resistance Additionally, annealing can give rise to the
further oxidation of the substrate in the NiTi/NT interface through the NT pathways and thereby to
higher corrosion resistance. The PLGA-coated sample also shows the highest corrosion resistance
compared to the other samples. The protective effect of polymer deposits on metallic substrates as a
physical barrier against the access of the electrolyte has been previously corroborated [[57], [58], [59]],
which is accompanied by a reduction in the leaching of metallic ions into the surrounding environment.
This is beneficial for NiTi implants which impose a concern regarding the release of toxic and
carcinogenic Ni ions into the surrounding tissue.

3.5. Cytocompatibility studies

The MTT assay was used to assess the DPSC cytocompatibility of the as-ground, as-anodized,
vancomycin-loaded and vancomycin-loaded PLGA-coated samples (Fig. 8). On the first day, there is no
significant difference between the cell viability of the samples, where all show suitable
biocompatibility. In the study of Park et al. [37] on the analysis of focal contact formation of
mesenchymal stem cells cultured on NTs with the diameter of 15–100 nm, it was shown that the

critical diameter of NTs for the best “integrin receptor” activation that is responsible for cell
proliferation, migration, differentiation and survival is in the range of 15–30 nm. As indicated in Fig. 2,
the NTs anodically-fabricated on NiTi in this study have a mean diameter of approximately 30 nm,
which can explain the appropriate DPSCs viability on the related surface.

Fig. 8. Cell viability of the control (a), as-ground (b), as-anodized (c), vancomycin-loaded (d) and vancomycinloaded PLGA-coated (e) samples, where * indicates significant difference with p-value < 0.05.

After three days of the cell culture, the as-anodized NTs show the lowest cell viability compared to the
other samples, which could be due to the fact that this non-annealed sample suffers from toxic fluorine
residuals on its surface. This finding is in agreement with previous studies on anodization of Ti alloys in
fluorine-containing electrolytes [16]. This problem is overcome by annealing at above 500 °C [16,35], as
the annealed NTs even after the drug loading present higher cytocompatibility than the as-anodized
NTs in this study. The suitable cytocompatibility of the bare and PLGA-coated vancomycin-loaded NTs
also suggests that the amount of vancomycin released until the third day is well tolerated by DPSCs.
These findings are corroborated by previous studies in which a similar release dosage of vancomycin
from NTs shows almost no negative effect on cell viability in vivo and in vitro [16].
On the 7th day of culture, the PLGA-coated drug-loaded NTs show the highest cell viability results. This
finding is supported by other studies in which biocompatibility is improved by using PLGA as a barrier
coating for the release of therapeutics [10,46,60]. The bare drug-loaded NTs show a significant
reduction in cell viability in this time point, which might to be resulted from the excessive amount of
vancomycin released from the device. This toxicity effect is consistent with studies conducted on local
vancomycin-delivery systems in which excessive vancomycin leaching (>300–500 μg/ml) leads to cell
death [50,61]. On the other hand, the controlled release of both vancomycin (Fig. 5) and metallic ions
(Fig. 7) from the PLGA-coated sample is inferred to be well-tolerated by the cells, resulting in 95% cell
viability at this time point. This verifies our hypothesis that PLGA coating of the NTs could control the
release of vancomycin above its MIC value, while maintaining an upper-bound release dosage that
does not reach vancomycin toxicity for DPSCs.

4. Conclusions

In this study, homogeneous open-top hydrophilic NTs are successfully fabricated on NiTi substrates by
a sequence of the anodization, sonication and annealing processes, then loaded with vancomycin and

finally coated with PLGA. The coated NTs provide a modulated drug-delivery kinetics than the bare
sample in terms of a reduced burst and prolonged total release within the therapeutic bound for
osteomyelitis. Moreover, the PLGA coating contributes to the enhancement of corrosion resistance,
and by extension to less metallic ions leaching of the substrate, which greatly enhances the DPSC cell
viability compared to the bare samples.
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